Empresa Bone Medical Limited Australian S.E.
Acciones
AU000000BNE6
Farmacéuticos
Precio de cierre
Otros sitios de cotización
|
||
- AUD | - |
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Howie McKibbon
CEO | Chief Executive Officer | - | 01/05/19 |
Vincent Ippolito
CHM | Chairman | 65 | 20/05/19 |
Chief Tech/Sci/R&D Officer | 68 | 01/03/21 | |
Henry Bosch
BRD | Director/Board Member | - | 01/07/16 |
Jack Hoblitzell
PRN | Corporate Officer/Principal | - | 24/09/21 |
Anthony Robinson
PRN | Corporate Officer/Principal | - | 01/03/21 |
Susan Park
SEC | Corporate Secretary | 49 | 17/04/23 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Stewart Washer
BRD | Director/Board Member | 54 | 21/02/19 |
Henry Bosch
BRD | Director/Board Member | - | 01/07/16 |
Vincent Ippolito
CHM | Chairman | 65 | 20/05/19 |
Matthew Callahan
FOU | Founder | 51 | 01/07/16 |
Daniel Sharp
BRD | Director/Board Member | - | 22/03/22 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 1 547 144 642 | 1 319 431 449 ( 85,28 %) | 0 | 85,28 % |
Información de la empresa
Botanix Pharmaceuticals Ltd.
661 Newcastle Street Unit D2
6007, Leederville
+
http://www.botanixpharma.comSector
Ventas por región
Varia. 1 de ene. | Capi. | |
---|---|---|
+15,72 % | 77,46 mil M | |
+13,65 % | 8940,95 M | |
-24,30 % | 4281,63 M | |
+12,79 % | 4176,73 M | |
+31,45 % | 4112,17 M | |
+10,97 % | 2226,93 M | |
-30,57 % | 2062,78 M | |
+8,99 % | 1970,87 M | |
-45,76 % | 1693,73 M |
- Bolsa de valores
- Acciones
- Acción BOT
- Acción
- Empresa Bone Medical Limited